$PCSA
Processa Pharmaceuticals, Inc.

2021 Q3 Form 10-Q Financial Statement

#000149315221027929 Filed on November 12, 2021

View on sec.gov

Income Statement

Concept 2021 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.338M
YoY Change 218.6%
% of Gross Profit
Research & Development $1.527M
YoY Change 362.62%
% of Gross Profit
Depreciation & Amortization $195.7K
YoY Change -6.8%
% of Gross Profit
Operating Expenses $3.060M
YoY Change 218.8%
Operating Profit -$3.111M
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.110M
YoY Change -0.97%
Income Tax -$122.4K
% Of Pretax Income
Net Earnings -$2.987M
YoY Change -2.7%
Net Earnings / Revenue
Basic Earnings Per Share -$0.19
Diluted Earnings Per Share -$192.3K
COMMON SHARES
Basic Shares Outstanding 15.53M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.09M
YoY Change 5685.82%
Cash & Equivalents $19.09M
Short-Term Investments
Other Short-Term Assets $1.507M
YoY Change 3666.5%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.67M
YoY Change 5399.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $5.540K
YoY Change -44.6%
Total Long-Term Assets $8.355M
YoY Change -9.32%
TOTAL ASSETS
Total Short-Term Assets $20.67M
Total Long-Term Assets $8.355M
Total Assets $29.03M
YoY Change 202.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $355.0K
YoY Change -17.45%
Accrued Expenses $471.4K
YoY Change -17.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $1.226M
YoY Change -53.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $408.8K
YoY Change 354.19%
Total Long-Term Liabilities $408.8K
YoY Change 155.48%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.226M
Total Long-Term Liabilities $408.8K
Total Liabilities $1.817M
YoY Change -55.25%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $27.21M
YoY Change
Total Liabilities & Shareholders Equity $29.03M
YoY Change 202.66%

Cashflow Statement

Concept 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.987M
YoY Change -2.7%
Depreciation, Depletion And Amortization $195.7K
YoY Change -6.8%
Cash From Operating Activities -$1.553M
YoY Change -5276.1%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -185.2K
YoY Change 15.74%
NET CHANGE
Cash From Operating Activities -1.553M
Cash From Investing Activities
Cash From Financing Activities -185.2K
Net Change In Cash -1.738M
YoY Change 1236.93%
FREE CASH FLOW
Cash From Operating Activities -$1.553M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
USD
CY2021Q3 us-gaap Notes Payable
NotesPayable
USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 PCSA Forgiveness Of Paycheck Protection Program Loan And Related Accrued Interest
ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest
USD
CY2020Q3 PCSA Forgiveness Of Paycheck Protection Program Loan And Related Accrued Interest
ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest
USD
PCSA Forgiveness Of Paycheck Protection Program Loan And Related Accrued Interest
ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest
USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
USD
CY2020Q2 PCSA Stock Dividend Distributed Due To Fullratchet Antidilution Adjustment
StockDividendDistributedDueToFullratchetAntidilutionAdjustment
USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
USD
PCSA Forgiveness Of Paycheck Protection Program Loan And Related Accrued Interest
ForgivenessOfPaycheckProtectionProgramLoanAndRelatedAccruedInterest
USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
PCSA Borrowings On Line Of Credit Payable From Related Party
BorrowingsOnLineOfCreditPayableFromRelatedParty
USD
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
USD

Files In Submission

Name View Source Status
0001493152-21-027929-index-headers.html Edgar Link pending
0001493152-21-027929-index.html Edgar Link pending
0001493152-21-027929.txt Edgar Link pending
0001493152-21-027929-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
pcsa-20210930.xsd Edgar Link pending
pcsa-20210930_cal.xml Edgar Link unprocessable
pcsa-20210930_def.xml Edgar Link unprocessable
pcsa-20210930_lab.xml Edgar Link unprocessable
pcsa-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending